ulipristal acetate


Also found in: Dictionary, Wikipedia.

ulipristal acetate

(o͞o′lə-prĭs′təl)
n.
A selective progesterone receptor modulator, C30H37NO4, used for emergency contraception.
References in periodicals archive ?
Pharmaceutical company Allergan plc (NYSE:AGN) reported on Wednesday the extension of the review of the New Drug Application (NDA) for ulipristal acetate for the medical treatment of abnormal uterine bleeding in women with uterine fibroids by the US Food and Drug Administration (FDA).
Ulipristal acetate is also the active substance of a single-dose medicine authorised for emergency contraception, ellaOne.
Data from randomized trials of ulipristal acetate and lovonorgestrel.
Research published in 2011 sparked vigorous debate--and some regulatory changes--when it reported that levonorgestrel EC pills may be ineffective for women who weigh at least 154 pounds, and that ulipristal acetate EC pills may be ineffective for women who weigh 194 pounds or more.
Pellicer, "Successful pregnancy after treatment with ulipristal acetate for uterine fibroids," Case Reports in Obstetrics and Gynecology, vol.
The second-generation antiprogestin ulipristal acetate (30 mg in a single dose) has been studied for use as emergency contraception and has been found to be highly effective and well-tolerated.
Furthermore, 88% of those who received same-day IUD placement reported ongoing IUD use at 3 months, and only 3% reported unintended pregnancy at 3 months, compared with 15% who received ulipristal acetate pills and 9% who received levonorgestrel pills, Ms.
have formed a commercial partnership to supply ulipristal acetate (UPA), a selective progesterone receptor modulator, to the U.
Two randomised clinical trials have found that ulipristal acetate (UPA), currently licensed for emergency contraceptive use up to five days (120 hours) after intercourse in Europe and the US, (1) is effective in treatment of heavy menstrual bleeding due to uterine fibroids.
2) There are 2 additional options: the copper intrauterine device (IUD), which is highly effective both as EC and as a long-term contraceptive, (6) and ulipristal acetate (UPA), which received US Food and Drug Administration (FDA) approval in 2010.
Ulipristal acetate, an emergency contraceptive that is effective for up to 5 days after unprotected intercourse, has been approved by the FDA.
The drug, ulipristal acetate (UPA), provides an effective non-surgical treatment for the common womb condition that can lead to pain, heavy periods and infertility, say scientists.